Ultragenyx Pharmaceutical
RARE
RARE
309 hedge funds and large institutions have $3.42B invested in Ultragenyx Pharmaceutical in 2025 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 117 increasing their positions, 108 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
3.53% more ownership
Funds ownership: 96.05% → 99.58% (+3.5%)
8% more repeat investments, than reductions
Existing positions increased: 117 | Existing positions reduced: 108
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Holders
309
Holding in Top 10
6
Calls
$149M
Puts
$87.7M
Top Buyers
| 1 | +$106M | |
| 2 | +$80.1M | |
| 3 | +$43.1M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$34.2M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$32.4M |
Top Sellers
| 1 | -$22.3M | |
| 2 | -$20.8M | |
| 3 | -$18.1M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$18M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$17.6M |